3 participants
Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-11-09
- Start Date:
- 2019-06-10
- Completion:
- 2020-01-21
Conditions
- Chronic Lymphocytic Leukemia
- CLL
- SLL
- Small Lymphocytic Lymphoma
Interventions
- DRUG
- COMBINATION_PRODUCT